The UK Court of Appeal has issued its judgment in one of the latest hearings in Neurim Pharmaceuticals v Generics (UK) relating to Neurim’s insomnia drug, Circadin. The Court of Appeal ruled that an exclusive licensee has...more
4/13/2022
/ Appeals ,
Corporate Counsel ,
Exclusivity ,
Intellectual Property Protection ,
IP License ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Standing ,
UK
The UK Government yesterday announced that its plans to ratify the Unified Patent Court Agreement (“UPCA”) will not be derailed by Brexit. The UK Minister of State for Intellectual Property, Baroness Neville Rolfe, made the...more
11/29/2016
/ Corporate Counsel ,
EU ,
Life Sciences ,
Patents ,
Pharmaceutical Patents ,
Popular ,
Ratification ,
UK ,
UK Brexit ,
Unified Patent Court ,
Unitary Patent